{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:57:57Z","timestamp":1761505077957,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cllc.2011.03.023","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T04:43:26Z","timestamp":1305866606000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chemotherapy-Induced Neutropenia Does Not Correlate With DNA Repair Gene Polymorphisms and Treatment Efficacy in Advanced Non\u2013Small-Cell Lung Cancer Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Vega","family":"Iranzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Sirera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy M.","family":"Bremnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elo\u00edsa","family":"Jantus-Lewintre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Tar\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Camps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2011.03.023_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.1988.6.4.633","article-title":"Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial","volume":"6","author":"Rapp","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.106.3.861","article-title":"Chemotherapy vs supportive care in advanced non-small-cell lung cancer","volume":"106","author":"Marino","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2011.03.023_bib3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1200\/JCO.1993.11.10.1866","article-title":"Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?","volume":"11","author":"Grilli","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib4","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1200\/JCO.1999.17.10.3188","article-title":"Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life","volume":"17","author":"Cullen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.cllc.2011.03.023_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.03.023_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.bjc.6690583","article-title":"The leucocyte nadir, a predictor of chemotherapy efficacy?","volume":"80","author":"Kvinnsland","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib8","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/1097-0142(20010615)91:12<2246::AID-CNCR1255>3.0.CO;2-4","article-title":"Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma","volume":"91","author":"Mayers","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.bjc.6690594","article-title":"Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF","volume":"80","author":"Poikonen","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.1997.49","article-title":"Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer","volume":"75","author":"Saarto","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjc.6601366","article-title":"Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer","volume":"89","author":"Cameron","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(05)70255-2","article-title":"Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials","volume":"6","author":"Di Maio","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","article-title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects","volume":"22","author":"Matullo","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2011.03.023_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3816\/CLC.2007.n.017","article-title":"Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy","volume":"8","author":"Camps","year":"2007","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2011.03.023_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdj135","article-title":"Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients","volume":"17","author":"De las Penas","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib18","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.1996.14.9.2590","article-title":"Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative","volume":"14","author":"Gurney","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.bjc.6600139","article-title":"How to calculate the dose of chemotherapy","volume":"86","author":"Gurney","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1470-2045(05)70296-5","article-title":"I don't underdose my patients \u2026 do I?","volume":"6","author":"Gurney","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2011.03.023_bib21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.bjc.6690583","article-title":"The leucocyte nadir, a predictor of chemotherapy efficacy?","volume":"80","author":"Kvinnsland","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjc.6601366","article-title":"Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer","volume":"89","author":"Cameron","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.03.023_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM197411072911903","article-title":"Amputation and adriamycin in primary osteosarcoma","volume":"291","author":"Cortes","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.03.023_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjc.6603831","article-title":"Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma","volume":"97","author":"Yamanaka","year":"2007","journal-title":"Br J Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:54:00Z","timestamp":1761504840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1525730411000246"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2011.03.023","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy-Induced Neutropenia Does Not Correlate With DNA Repair Gene Polymorphisms and Treatment Efficacy in Advanced Non\u2013Small-Cell Lung Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2011.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}